Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
825
-
Total 13F shares, excl. options
-
341M
-
Shares change
-
+36.6M
-
Total reported value, excl. options
-
$11.5B
-
Value change
-
+$1.18B
-
Put/Call ratio
-
0.21
-
Number of buys
-
329
-
Number of sells
-
-458
-
Price
-
$33.82
Significant Holders of GSK plc - SPONSORED ADR (GSK) as of Q4 2024
1,010 filings reported holding GSK - GSK plc - SPONSORED ADR as of Q4 2024.
GSK plc - SPONSORED ADR (GSK) has 825 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 341M shares
.
Largest 10 shareholders include Dodge & Cox (68.4M shares), FMR LLC (52.8M shares), PRIMECAP MANAGEMENT CO/CA/ (25.3M shares), JTC Employer Solutions Trustee Ltd (20.3M shares), Fisher Asset Management, LLC (18.8M shares), GOLDMAN SACHS GROUP INC (9.68M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.57M shares), Royal Bank of Canada (7.17M shares), STATE STREET CORP (7.03M shares), and UBS Group AG (6.48M shares).
This table shows the top 825 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.